Budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy starting from data of the Atlas-M trial

Simona Di Giambenedetto, Umberto Restelli, Carmela Nappi, Davide Croce

Risultato della ricerca: Contributo in rivistaArticolo in rivista

9 Citazioni (Scopus)

Fingerprint

Entra nei temi di ricerca di 'Budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy starting from data of the Atlas-M trial'. Insieme formano una fingerprint unica.

Medicine & Life Sciences

Business & Economics

Social Sciences